Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 29;10(5):e27333.
doi: 10.1016/j.heliyon.2024.e27333. eCollection 2024 Mar 15.

The role of Kolaviron, a bioflavonoid from Garcinia kola, in the management of cardiovascular diseases: A systematic review

Affiliations

The role of Kolaviron, a bioflavonoid from Garcinia kola, in the management of cardiovascular diseases: A systematic review

Francis J Olatoye et al. Heliyon. .

Abstract

While the cardiovascular effects of Kolaviron (KV) and Garcinia kola (GK) are documented in the literature, a thorough search through literature revealed a fragmentation of information on the effect of KV and GK on cardiovascular diseases (CVDs). This systematic review aims to evaluate and summarize preclinical or clinical evidence on the effect of KV and GK on CVDs. Using the PRISMA guidelines, a systematic literature search was conducted in five medical databases (PubMed, Cochrane, EMBASE, CINAHL, and Web of Science). Inclusion criteria included both in vivo and in vitro studies related to CVDs. Eligible studies included those in which specific clinical parameters, CVD biomarkers, or voltage-gated channel effects were reported. The quality of the included studies was assessed using a modified Collaborative Approach to Meta-Analysis and Review of Animal Data from the Experimental Studies (CAMARADE) checklist. A total of 22 studies were included in this systematic review. The median and mean values of the included studies' quality scores were 6 and 5.864 ± 0.296, respectively. The results from the quality assessment of included studies validate their suitability, usefulness, and fit. Based on this systematic review, the effect of KV and GK on CVDs can be divided into eight emerging trends: (1) Anti-hypertensive/Blood pressure lowering effect; (2) Lipid profile improvement effect (3) Anti-atherosclerotic effect; (4) Anti-thrombotic effect; (5) Cardioprotection; (6) Vasodilatory effect; (7) Antioxidant effects; and (8) Genetic expression and therapeutic target for cardiovascular dysfunction. From this systematic review, it can be concluded that KV is helpful in managing CVD risk factors such as hypertension and high lipids/cholesterol. Several included studies in this review demonstrated the antihypertensive, lipid improvement, antioxidant, and signaling pathway modulation effects of KV. This potentially makes KV a good therapeutic target for the management of CVDs.

Keywords: Antioxidants; Cardiovascular diseases; Flavonoid; Garcinia kola; Hypertension; Kolaviron.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Image 1
Graphical abstract
Fig. 1
Fig. 1
Flow diagram of literature search and selection of papers included in systematic review.
Fig. 2
Fig. 2
Risk of bias assessment of eligible (selected) studies.

Similar articles

References

    1. World Health Organization . WHO Fact Sheets; 2021. World Health Organisation Key Facts on Cardiovascular Diseases (CVDs)https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases...
    1. Forouzanfar M.H., Liu P., Roth G.A., Ng M., Biryukov S., Marczak L., et al. Global burden of hypertension and Systolic blood pressure of at least 110 to 115 mm Hg. JAMA, J. Am. Med. Assoc. 2017;317(6):648. 1990-2015.[Erratum appears in JAMA. 2017 Feb 14. PMID: 28114659] - PubMed
    1. Vaduganathan M., Mensah G.A., Turco J.V., Fuster V., Roth G.A. The global burden of cardiovascular diseases and risk: a Compass for future health. J. Am. Coll. Cardiol. 2022 doi: 10.1016/j.jacc.2022.11.005. - DOI - PubMed
    1. Tsao C.W., Aday A.W., Almarzooq Z.I., Alonso A., Beaton A.Z., Bittencourt M.S., et al. Heart disease and stroke Statistics-2022 update: a report from the American heart association. Circulation. 2022;145 doi: 10.1161/CIR.0000000000001052. - DOI - PubMed
    1. Ruel M. Tackling the other Pandemic: the Rise in cardiovascular diseases. Can. J. Cardiol. 2022;38:849–851. doi: 10.1016/j.cjca.2022.06.001. - DOI

LinkOut - more resources